Zoledronic acid induced osteonecrosis of tibia and femur

Indian Journal of Cancer

Volumn 46, Issue 3, 2009, Pages 249-250

  Gupta, S ^a   Jain, P ^a   Kumar, P ^a   Parikh, P M ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; MEDRONATE TECHNETIUM TC 99M; PAMIDRONIC ACID; ZOLEDRONIC ACID;

ADULT; BONE METASTASIS; BONE NECROSIS; BONE SCINTISCANNING; BREAST CANCER; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CASE REPORT; DIAGNOSTIC IMAGING; FEMALE; FEMUR; HUMAN; JAW OSTEONECROSIS; LETTER; MANDIBLE; MAXILLA; MULTIPLE MYELOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; SPINE METASTASIS; TIBIA; TREATMENT OUTCOME;

BONE DENSITY CONSERVATION AGENTS; BREAST NEOPLASMS; DIPHOSPHONATES; FEMALE; FEMUR; HUMANS; IMIDAZOLES; MIDDLE AGED; OSTEONECROSIS; TIBIA;

EID: 67651149763     PISSN: 0019509X     EISSN: 19984774     Source Type: Journal    
DOI: 10.4103/0019-509X.52967     Document Type: Letter

References (5)

1. Michaelson MD, Smith MR. Bisphosphonates for treatment and prevention of bone metastases. J Clin Oncol 2005;23:8219-24.
2. Pavlakis N, Schmidt R, Stockler M. Bisphosphonates for breast cancer. Cochrane Database Syst Rev 2005;3:CD003474.
3. Durie BG, Katz M, McCoy J, Crowley J. Osteonecrosis of the jaw and bisphosphonates. N Engl J Med 2005;353:99.
4. Migliorati CA, Schubert MM, Peterson DE, Seneda LM. Bisphosphonate- associated osteonecrosis of mandibular and maxillary bone: An emerging oral complication of supportive care in cancer. Cancer 2005;104:83-93.
5. Badros A, Weikel D, Salama A, Goloubeva O, Schneider A, Rapoport A, et al. Osteonecrosis of the jaw in multiple myeloma patients: Clinical features and risk factors. J Clin Oncol 2006;24:945-52.